Literature DB >> 1571115

Fine-needle aspiration in the diagnosis of salivary gland disorders in the community hospital setting.

D B Pitts1, R L Hilsinger, E Karandy, J C Ross, J E Caro.   

Abstract

From 1983 to 1988, 47 patients with salivary gland disorders were assessed with fine-needle aspiration (FNA) before surgery. The preoperative fine-needle diagnoses were then compared with the postoperative pathologic findings. In the same period, 63 patients from two other community hospitals who had been evaluated preoperatively with FNA were studied retrospectively. The overall sensitivity of FNA for salivary neoplasms was 80.6%. Fine-needle aspiration was more sensitive in identifying benign tumors (88.4%) than malignant neoplasms (58.3%) and was least sensitive in identifying nonneoplastic salivary diseases (35.3%). Pleomorphic adenomas were correctly identified preoperatively in 96.2% of cases, whereas for malignant neoplasms, the diagnostic accuracy was highest for mucoepidermoid carcinoma (50%). To demonstrate the strengths of FNA as a diagnostic tool, as well as to delineate its limitations, we present our 5-year experience. Our FNA results are similar to those reported by the major European and American referral centers. Because our medical centers are community based, our results may more accurately reflect those seen by otolaryngologists in private practice. To date, no evidence of tumor seeding along the FNA tract has been reported.

Entities:  

Mesh:

Year:  1992        PMID: 1571115     DOI: 10.1001/archotol.1992.01880050025005

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Value of imaging and aspiration cytology in the diagnosis of oncocytic carcinoma.

Authors:  T Pusiol; I Franceschetti; I Piscioli; M A Beltrame; M Polce; C Sassi
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-04       Impact factor: 2.124

2.  Comparison of fine-needle aspiration and core needle biopsy under ultrasonographic guidance for detecting malignancy and for the tissue-specific diagnosis of salivary gland tumors.

Authors:  H-J Eom; J H Lee; M-S Ko; Y J Choi; R G Yoon; K J Cho; S Y Nam; J H Baek
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-12       Impact factor: 3.825

3.  Application of the Milan System for Reporting Submandibular Gland Cytopathology: An international, multi-institutional study.

Authors:  Zahra Maleki; Zubair Baloch; Ryan Lu; Khurram Shafique; Sharon J Song; Kartik Viswanathan; Rema A Rao; Holly Lefler; Aisha Fatima; Austin Wiles; Vickie Y Jo; He Wang; Guido Fadda; Celeste N Powers; Syed Z Ali; Liron Pantanowitz; Momin T Siddiqui; Ritu Nayar; Jerzy Klijanienko; Guliz A Barkan; Jeffrey F Krane; Esther D Rossi; Fabiano Callegari; Ivana Kholová; Massimo Bongiovanni; William C Faquin; Marc P Pusztaszeri
Journal:  Cancer Cytopathol       Date:  2019-05-03       Impact factor: 5.284

4.  An audit of surgery of the parotid gland.

Authors:  G T Deans; K Briggs; R A Spence
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

5.  A cytohistologic correlation of mucoepidermoid carcinoma: emphasizing the rare oncocytic variant.

Authors:  Timothy V Wade; Virginia A Livolsi; Kathleen T Montone; Zubair W Baloch
Journal:  Patholog Res Int       Date:  2011-03-15

6.  Diagnostic accuracy of fine needle aspiration cytology in parotid lesions.

Authors:  Naeem Sultan Ali; Shabbir Akhtar; Montasir Junaid; Sohail Awan; Kanwal Aftab
Journal:  ISRN Surg       Date:  2011-05-31

7.  Diagnostic challenges in cytology of mucoepidermoid carcinoma: Report of 6 cases with histopathological correlation.

Authors:  Tessy P Joseph; Cicy P Joseph; P S Jayalakshmy; Usha Poothiode
Journal:  J Cytol       Date:  2015 Jan-Mar       Impact factor: 1.000

Review 8.  Salivary gland neoplasms.

Authors:  Terry A Day; John Deveikis; M Boyd Gillespie; John K Joe; Besim Ogretmen; J David Osguthorpe; Susan G Reed; Mary S Richardson; Michael Rossi; Ranjiv Saini; Anand K Sharma; Robert K Stuart
Journal:  Curr Treat Options Oncol       Date:  2004-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.